Multicenter, real-world experience with lenvatinib for patients with advanced hepatocellular carcinoma in Japan

被引：0
|
作者：
Sho, Takuya [1 ]
Suda, Goki [1 ]
Ogawa, Koji [1 ]
Nakai, Masato [1 ]
Morikawa, Kenichi [1 ]
Sakamoto., Naoya [1 ]
机构：
[1] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT510
引用
收藏
页码：S909 / S909
页数：1
相关论文
共 50 条
  • [31] Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysis
    Hiraoka, Atsushi
    Kumada, Takashi
    Atsukawa, Masanori
    Hirooka, Masashi
    Tsuji, Kunihiko
    Ishikawa, Toru
    Takaguchi, Koichi
    Kariyama, Kazuya
    Itobayashi, Ei
    Tajiri, Kazuto
    Shimada, Noritomo
    Shibata, Hiroshi
    Ochi, Hironori
    Tada, Toshifumi
    Toyoda, Hidenori
    Nouso, Kazuhiro
    Tsutsui, Akemi
    Nagano, Takuya
    Itokawa, Norio
    Hayama, Korenobu
    Imai, Michitaka
    Joko, Kouji
    Koizumi, Yohei
    Hiasa, Yoichi
    Michitaka, Kojiro
    Kudo, Masatoshi
    CANCER MEDICINE, 2019, 8 (08): : 3719 - 3728
  • [32] Efficacy and safety of lenvatinib and pembrolizumab as first-line treatment for advanced renal cell carcinoma patients: real-world experience in Japan
    Takuto Hara
    Kotaro Suzuki
    Yasuyoshi Okamura
    Koji Chiba
    Ryo Sato
    Yuto Matsushita
    Keita Tamura
    Gaku Ishikawa
    Atsushi Otsuka
    Hideaki Miyake
    International Journal of Clinical Oncology, 2024, 29 (12) : 1931 - 1936
  • [33] Real-world experience with Lenvatinib in the management of Hepatocellular Carcinoma: A single-center Indian experience.
    Rauthan, Amit
    Somashekhar, S. P.
    Patil, Poonam
    Zaveri, Shabber
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Real-World Effectiveness of First Line Lenvatinib Therapy in Advanced Hepatocellular Carcinoma: Current Insights
    de Castria, Tiago Biachi
    Kim, Richard
    PRAGMATIC AND OBSERVATIONAL RESEARCH, 2024, 15 : 79 - 87
  • [35] The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in China: A retrospective, real-world study.
    Yang, Xin-Rong
    Guo, De-Zhen
    Chen, Fei-Yu
    Fan, Jia
    Jian, Zhou
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] Real-world effectiveness of lenvatinib monotherapy among unresectable hepatocellular carcinoma patients in the USA
    Singal, Amit G.
    Nagar, Saurabh P.
    Hitchens, Abby
    Davis, Keith L.
    Iyer, Shrividya
    FUTURE ONCOLOGY, 2021, 17 (21) : 2759 - 2768
  • [37] Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events
    Ben Khaled, Najib
    Moeller, Marie
    Jochheim, Leonie S.
    Leyh, Catherine
    Ehmer, Ursula
    Boettcher, Katrin
    Pinter, Matthias
    Balcar, Lorenz
    Scheiner, Bernhard
    Weich, Alexander
    Leicht, Hans Benno
    Zarka, Valentina
    Ye, Liangtao
    Schneider, Julia
    Piseddu, Ignazio
    Oecal, Osman
    Rau, Monika
    Sinner, Friedrich
    Venerito, Marino
    Gairing, Simon Johannes
    Foerster, Friedrich
    Mayerle, Julia
    Toni, Enrico N. De
    Geier, Andreas
    Reiter, Florian P.
    JHEP REPORTS, 2024, 6 (06)
  • [38] Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective Study
    Xia, Dongdong
    Bai, Wei
    Wang, Enxin
    Li, Jiaping
    Chen, Xiaoming
    Wang, Zhexuan
    Huang, Mingsheng
    Huang, Ming
    Sun, Junhui
    Yang, Weizhu
    Lin, Zhengyu
    Wu, Jianbing
    Li, Zixiang
    Yang, Shufa
    Zhu, Xu
    Chen, Zaizhong
    Zhang, Yanfang
    Fan, Wenzhe
    Mai, Qicong
    Ding, Rong
    Nie, Chunhui
    Feng, Long
    Li, Xueda
    Huang, Wukui
    Sun, Jun
    Wang, Qiuhe
    Lv, Yong
    Li, Xiaomei
    Luo, Bohan
    Wang, Zhengyu
    Yuan, Jie
    Guo, Wengang
    Li, Kai
    Li, Bing
    Li, Ruijun
    Yin, Zhanxin
    Xia, Jielai
    Han, Guohong
    LIVER CANCER, 2022, 11 (04) : 368 - 382
  • [39] The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study
    Chen, Jinbin
    Xiong, Peiyao
    Nie, Man
    Pan, Yangxun
    Wang, Juncheng
    Hu, Dandan
    Zhou, Zhongguo
    Zhang, Yaojun
    Chen, Minshan
    Xu, Li
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (06) : 2491 - 2500
  • [40] The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study
    Jinbin Chen
    Peiyao Xiong
    Man Nie
    Yangxun Pan
    Juncheng Wang
    Dandan Hu
    Zhongguo Zhou
    Yaojun Zhang
    Minshan Chen
    Li Xu
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 2491 - 2500
12345